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Background
Myostatin (MSTN), a member of the transforming growth
factor beta family, negatively regulates skeletal muscle
mass. Deletion of the Mstn gene results in increased
muscle mass. Also, Mstn-/- mice and mice expressing a
dominant negative MSTN receptor (activin receptor type
IIB, ACVR2B) show decreased adipose tissue. Mstn-/-
mice fed a high fat diet gain less weight, have improved
glucose tolerance and are more sensitive to insulin when
compared to wild type controls. We are interested in char-
acterizing molecules that may be downstream of MSTN
signaling. We identified serotonin as a potential molecule
that may interact with MSTN in skeletal muscle. Seroto-
nin is thought to regulate both metabolism and cardiac
hypertrophy, but it is not clear if serotonin is synthesized
and functions in the skeletal muscle. We hypothesize that
serotonin regulates skeletal muscle mass and metabolism,
and the serotonin and myostatin pathways interact with
each other.
Materials and methods
Microarray screening was carried out on gastrocnemius
muscle from transgenic mice carrying dominant negative
ACVR2B and wild type littermates. Selected results were
validated by real time qPCR (RT-qPCR) using cDNA from
transgenic muscle and muscle from mice injected with a
MSTN inhibitor (a soluble ACVR2B). Rat L6 myoblasts
were differentiated in horse serum with or without seroto-
nin. Myotube size was determined from anti-myosin heavy
chain immunofluorescence using NIC Elements software
(Nikon). Serotonin concentrations in transgenic muscle
and L6 cells were determined by HPLC.
Results
Expression of tryptophan hydroxylase 1 (Tph1), the
enzyme that catalyzes the rate limiting step in serotonin
synthesis was significantly increased by microarray in
transgenic mice and by RT-qPCR in mice receiving the
soluble receptor. Serotonin significantly promoted longitu-
dinal growth of skeletal muscle fibers in vitro. Increased
branching, differentiation and fusion of myoblasts into
myotubes were also observed. Serotonin was detectable in
muscle from transgenic mice and in L6 myoblasts and
myotubes.
Conclusions
This study is the first to show that serotonin is found in
skeletal muscle, and promotes muscle growth in vitro. We
also show that the Tph1 enzyme is expressed in skeletal
muscle, and that Tph1 expression increases with hypertro-
phy after MSTN inhibition. To elucidate the mechanism
by which MSTN and serotonin pathways interact with
each other, and their role in muscle growth and insulin
signaling, we are using specific agonists and antagonists
along with RT-qPCR to determine which of the 15 seroto-
nin receptors are expressed by skeletal muscle fibers in
presence or absence of MSTN. Since Mstn-/- mice show
improved glucose tolerance, and serotonin has previously
been implicated in insulin secretion and glucose uptake,
we are interested in understanding how MSTN and sero-
tonin may regulate glucose metabolism in skeletal muscle.
We hope that this study will not only shed light on normal
muscle development and metabolism, but will also suggest
potential targets that could be manipulated therapeutically
with respect to muscle wasting diseases, diabetes, and
obesity.
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